In time, whatever can go wrong, will. That’s the surprising finding of our research on shocks to the pharmaceutical business system. Companies can expect mild disruptions every couple of years, and major breaks twice a decade.
To read the article, see “Four ways pharma companies can make their supply chains more resilient,” September 23, 2021.